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Günümüzde ruhsal sorunlar önemli bir halk sağlığı sorunu haline gelmiş olup, bunlar içerisinde gebelikte en sık görüleni depresyondur. Gebelikte yaşanan 
depresyonun, hem gebelik komplikasyonlarını arttırdığı hem de annenin ve fetüsün sağlığını olumsuz etkilediği bilinmektedir. Gebelikte depresyon 
ve depresif semptom görülme sıklığı %10-30 arasında değişmektedir. Risk faktörleri kültürler arasında farklılık göstermekte olup, genetik, psikolojik, 
çevresel, sosyal ve biyolojik faktörlerin etkileri üzerinde durulmaktadır. Tedavi almayan gebelerde, maternal morbidite ve mortalite hızı artmakta, obstetrik 
komplikasyonlar ve olumsuz fetal sonuçlar görülmekte, postpartum depresyon insidansında artış saptanmaktadır. Tüm bu önemli sonuçları nedeniyle, 
gebeleri takip eden sağlık personeli, gebelik ve doğum sonrası depresyonun sıklığı, semptomları ve tarama yöntemleri, tanı almayan veya tedavi edilmeyen 
depresyonun anne ve bebek sağlığı üzerindeki etkileri ve erken tanının önemi hakkında bilgilendirilmelidir. Risk altındaki gebeler saptanmalı ve taramalar 
sonucunda riskli bulunan gebeler ilgili merkezlere yönlendirilebilmelidir. Bu amaçla bu yazıda, gebelikte depresyonun tanımı, sıklığı, risk faktörleri, 
komplikasyonları, taraması, tedavisi ve bu süreçte yapılması gerekenler kısaca gözden geçirilmiştir. J Turk Soc Obstet Gynecol 2015;2:102-13
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Abstract
Nowadays, mental problems have become an important health issue, the most frequent of which in pregnancy is depression. Gestational depression 
is known to increase gestational complications and negatively affect maternal and fetal health. The frequency of gestational depression and depressive 
symptoms are 10-30%. Risk factors vary according to genetic, psychologic, environmental, social, and biologic factors. Maternal morbidity and mortality 
rates increase in pregnant women who do not receive treatment, obstetric complications and negative fetal consequences are seen, and the incidence of 
postpartum depression increases. Due to all these important consequences, healthcare providers who manage pregnant women should be informed about 
the frequency, symptoms, and screening methods of postpartum depression, the significance of the consequences of undiagnosed and untreated depression 
on the health of mother and baby, and the importance of early diagnosis. Pregnant women who are at risk should be screened and detected, and directed 
to related centers. In this review, we briefly review the definition of gestational depression, its frequency, risk factors, complications, screening, treatments, 
and the procedures that need to be performed the diagnostic process. J Turk Soc Obstet Gynecol 2015;2:102-13
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Introduction
Today, the incidence of mental problems are significantly 
increased, and have become both an individual and a public 
issue. Of all the mental disorders, the most frequent and the one 
that carries the greatest burden is depression. Depression is an 
illness that decreases onereaquality of life by making functions, 
creativity, happiness, and satisfaction fade away and reduces 
the capacity for work. Its frequency, chronicity, high rates of 
recurrence, and suicide incidence makes it an important health 
issue and the third most important disease in the world in terms of 
its burden. Depression is ranked as the eighth greatest healthcare 
burden in low-income countries; however, it is number one in 
countries that have average and higher incomes(1,2). Depression 
is the most frequent of all mental disorders in the gestational 
period. In past years, the gestational period was known to bring 
a sensation of well-being and this was thought to protect against 
mental disorders. However, today it has been recognized that 
gestational depression has been missed because the physiologic 
changes and symptoms seen in depression are similar to those 
in the gestational and postpartum period (e.g. sleeping habits, 
appetite, weight changes, and fatigue)(3). According to World 
Health Organizationes, pression hurden ncrea(4), 1 in 3-5 
pregnant women in developing countries, and 1 in 10 pregnant 
women in developed countries have severe mental problems 
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either during gestation or in the postpartum period. Depression 
in pregnancy is the most important risk factor for postpartum 
complications and fetal-neonatal problems, and is more frequent 
than in the postpartum period. Gestational depression has 
become an important issue. Despite it being such an important 
health issue, the development of depression during pregnancy 
is not being detected and consequently women are not receiving 
proper treatment because there is still no screening program 
and healthcare providers are not yet sufficiently knowledgeable. 
Here, we briefly review, the definition of gestational depression, 
its frequency, risk factors, symptoms, risks for mother and baby, 
screening, and treatment.
The prevalence of gestational depression in the world 
and in turkey
According to the literature, the frequency of gestational 
depression and depressive symptoms is between 10-30%(5-9). 
In the study of Bödecs et al. performed in Hungary(10), the 
prevalence of gestational depression was found to be 18%, the 
result of the Marcus et al. study in the United States of America 
was 20%, and Kurki et al. reported 30% in Finland(11,12). In 
the studies in our country, Turkey, the gestational depression 
prevalence has been reported to be between 27.9-33.1%(13-17). 
As these numbers are higher than the values of the world, it is 
estimated that factors in the lives of pregnant women in our 
country affect the prevalence and intensity of the gestational 
depression (e.g. teenage pregnancies, frequent pregnancies, 
economic problems, low education levels, violence in the 
family, crowded families)(14,15).
Risk factors of gestationel depression
As shown in Table 1, the potential risk factors of gestational 
depression should be considered through different 
perspectives. In the literature, the affects of genetic, psychologic, 
environmental, social and biologic factors are considered. 
History of depression, history of depression in the family, 
marital problems, lack of partner, lack of social support, negative 
experiences, violence, lower social and economic levels, poor 
obstetric history (abortus, death), unwilling pregnancies, very 
early or late pregnancies, and low education levels form the 
risk factors and these vary according to cultures(6,7,18-20). In 
a randomized study conducted by Leigh et al. in Australia 
on 367 pregnant women(21), depression risk was found to 
be high in those who lacked self-respect, were anxious in 
pregnancy, lacked social support, had lower incomes, and 
those who experienced a significant trauma. In the study of 
Figueiredo et al. performed in Portugal, teenaged pregnant 
girls showed significantly more depressive symptoms during 
their pregnancies and postpartum periods(22). Those who 
receive antidepressants are under the risk of depression and its 
recurrence when they terminate their medication after getting 
pregnant; the first 8 weeks after termination of medication carry 
the greatest risk. Cohen et al. found that relapses of depression 
occurred in 43% women who had had a major attack of 
depression, 26% of those who continued their medication, and 
68% of those who terminated their medication depression(23). 
In most cases, miscommunication, unwilling pregnancies, and 
marital problems are more frequent. All complications seen in 
pregnancy and all the medical problems that make a pregnancy 
risky have the potential to cause psychiatric symptoms. The 
incidence of anxiety and depression is higher in the gestational- 
and postpartum period in pregnant women who have medical 
problems like hypertension and diabetes, and women who have 
obstetric problems like preeclampsia, risk of early labor, poli/
oligohidramnios, and intrauterine growth retardation when 
compared with those without medical problems(24,25).
Findings and symptoms of gestational depression
It can frequently be hard to diagnose gestational depression 
because the findings and symptoms of depression in pregnant 
women are so similar to the physiologic changes and symptoms 
during pregnancy. The major findings and symptoms of 
depressed mood during pregnancies are; changes in sleep 
habits and appetite, pain, fluctuation in sensations, abnormal 
fatigue, lack of libido and concentration, and anxiety and 
fears about delivery. Even if these symptoms of depression 
cannot be separated from the symptoms of general depression, 
somatic symptoms like nausea, stomach ache, tachypnea, 
hyperpnoea, headache, gastrointestinal symptoms, tachycardia, 
and lightheadedness are significantly more likely to be seen, 
hyperactive physical symptoms have to be important.
The affects and consequences od the gestational 
depression
The consequences of gestational depression can be seen in 
Table 2, grouped as maternal, fetal, and childhood originated. 
Table 1. Risk factors for antepartum depression
Previous depression episodes
Family history of depression 
Discord/uneasiness within the family
Lack of partner
Lack of social support
Negative life experiences
Domestic violence
Unplanned pregnancy
Demographic characteristics
Low socio-economic status
Early/advanced maternal age
Low educational level
Unemployment
Poor obstetric history (abortus/history of still birth)
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Maternal morbidity, mortality, and suicide attempt rates 
increase in women who have depression during pregnancy 
and do not receive treatment. Gestational depression affects 
both the physical and mental health of women by decreasing 
their self-hygiene and increasing gestational complications, 
which negatively effect the health of the fetus. Preeclampsia 
and eclampsia, early-onset labor, babies with lower weight, 
and APGAR have been found to be more related to the 
depression during pregnancy(12,26,27). If no is action taken 
during pregnancy and depression continues, the risk increases 
in the babies and children. These negative effects present as 
problems in bond development between babies and mothers, 
growth retardations, development of motor and linguistic skills, 
and increased risk in gastrointestinal and lower respiratory 
infections(28-30). Sensory and cognitive problems are known 
to develop in such children in later years(31,32). Many studies 
have proven that gestational depression is the most important 
risk factor of postpartum depression and depression continues 
during the postpartum period in 50% of women who had 
depression during their pregnancies(21,33,34). 
Effects of gestational depression on pregnant women
Gestational depression decreases mothers’ self-hygiene, which 
can harm cognitive functions in terms of decision-making ability, 
this situation may be correlated with lack of concentration 
during pregnancy and use addictive substances. Many studies 
have shown that women with gestational depression use 
tobacco and alcohol and addictive substances during their 
pregnancies(35,36). In the study of Zuckerman et al., depression 
in pregnancy was highly correlated with tobacco, alcohol, and 
cocaine use(37). Pregnant women with symptoms of depression 
are more likely to miss their screenings, tend to receive less 
medical help, and have less pre-delivery help. These patients 
generally have nutritional and sleeping problems and gain less 
weight than the normal because of their loss of appetite. It is 
known that those who have depression have decreased social 
function, become introvert, and have fears about becoming 
parents. In patients for whom depression continues after delivery, 
provision of reduced care, increased anxiety, and thoughts 
about harming offspring can be seen. Severe depression may 
lead to self-harm, an increased risk of showing brutal actions, 
and may cause suicide(38-41). Hesse et al. showed that 5% of 
patients who had depression during pregnancies and received 
no treatment had attempted suicide(42). Of the causes of death 
directly connected to pregnancy, suicide accounts for 2.4% of 
deaths related to pregnancy, and 3.2% of maternal deaths.
Screening of gestational depression
It is vital to diagnose depression in pregnant women early 
because it is important to give medication to decrease long-
term negative consequences. The American College of 
Obstetricians and Gynecologists Committee advises that 
all women, regardless of social status, education level, and 
ethnicity, should be screened at least once every trimester for 
mental disorders(43). The screening should be done using 
short, reliable, valid methods that have high sensitivity and 
low false positive rates. The commonly-used methods for the 
screening of depression during pregnancy include the Patient 
Health Questionnaire, Beck Depression Inventory, Center 
for Epidemiologic Studies Depression Scale, Two-Sentence 
test, and the Edinburgh Postpartum Depression Scale(44-46). 
Supplements 1-4 demonstrate all screening tools mentioned 
above for gestational depression. 
Treatment approaches in gestational depression
The treatment of gestational depression is becoming an 
important issue for researchers and physicians. In the last few 
years, physicianss studies have mostly been about concerns 
of medications used in the treatment of depression and how 
they effect the fetus; however, now it is understood that the 
real problem is depression without medication. Today, the view 
is that gestational depression should be treated because of its 
negative consequences on both mother and fetus. There are 3 
problems that clinicians have to solve when they meet a mother 
in depression:
Women who become pregnant while using antidepressants and 
continue using them for some time without being aware that 
they are now pregnant: according to todaya mother in dethis 
situation carries low risk; however, a conversation with the 
mother and relatives should take place to provide information 
about the risks and a decision about the pregnancy has to be 
made.
Depression began before pregnancy and is ongoing or the 
depression occurred during pregnancy: For women who 
have not been given medication, if psychotherapy cannot be 
undertaken or is insufficient, treatment especially with an SSRI 
Table 2. Outcomes of antenatal depression
Maternal outcomes
Hypertensive disorders of pregnancy (Preeclampsia-Eclampsia)
Preterm birth
Postpartum depression
Fetal outcomes
Baby small for gestational age 
Low birth weight
Low APGAR scores
Childhood outcomes
Growth retardation
Delay in motor and language development
Increased risk of gastrointestinal and lower respiratory tract 
infections
Cognitive-behavioral-emotional problems
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is the most accepted approach that is accepted the most because 
the risk of damage to mother and baby is high.
Babies with possible withdrawal symptoms whose mother had 
medical treatment during pregnancy: Most of these symptoms 
can be cured by general support but it is important for physicians 
to be aware of the situation and closely observe the baby. Patients 
and their relatives have to be involved in all decision processes. 
It is extremely difficult to form a treatment method that can be 
applied to all pregnant women. It is the responsibility of the 
physician to evaluate all cases on an individual basis and form a 
treatment strategy for the sake of mother and child.
Psychotherapy
Psychotherapies are the first choice in the treatment of 
depression because of the possible adverse effects of medical 
therapy, especially in mild and moderate depression (for patients 
who do not have recurrent depressive episodes, severe weight 
loss, suicide attempts and who are not inpatients) (Grade 2B). 
Short-term physiotherapies in particular have been found to be 
effective and they are being used more frequently. Interpersonal 
and cognitive behavioral therapies are reported to be efficient 
for mild and moderate depression.
Interpersonel psychotherapies
Interpersonal physiotherapies are short therapies that focus 
on interpersonal problems that aim to decrease depressive 
symptoms and fix interpersonal functions. They also serve to 
help form social support systems that will help to cope with the 
stress. Acute interpersonal problems can be discussed in such an 
environment; cognitive processes and previous relations are not 
addressed in this way. Treatment time is between 12-20 weeks, 
once a week(47-49). It has been shown to be effective for both 
gestational and postpartum depression. On the study reported 
on 120 women who had major depression and had given birth 
the women were separated into 2 randomized groups, one of 
which received interpersonal psychotherapy for 12 weeks(50). 
The authors found a significant difference in terms of remission 
for the group that received physiotherapy (37.5%) compared 
with the con-treatment group (13.7%).
Cognitive behavioral therapy
Cognitive behavioral therapy is one of the most commonly-
used psychotherapy methods of the world, and is effective for 
most mental disorders. This therapy aims to fix depression by 
modifying schemes formed by cognitive distortions, which 
effect emotions and result in depression. Approximately 12 
sessions are needed for depression.
Medical treatments
Medical treatment should be considered when psychotherapies are 
difficult to perform or become unsuccessful, in cases of moderate 
depression, history of severe depression, positive outcomes of 
medical treatments, and the possibility of the mothern, positive 
outcomes high. Even though the reliability of these medications not 
yet proved due to the difficulty of performing studies on pregnant 
women, according to the outcomes of the actual medications, 
there is no major malformations affect in fetuses. Before starting 
a medication in pregnant women, risks for a developing 
fetus must be evaluated in terms of malformations of organs, 
teratogenesis, neonatal withdrawal and toxicity syndromes, and 
long-term behavioral effects. Before initiating a medication, the 
potential harms and benefits and severity of depression should 
be considered(51,52). The treatment of gestational depression is 
summarized in Table 3.
SSRIs: SSRIs are the first-choice medications according to 
the literature (Grade 2B). They are a group C medication 
for pregnant women. The first medication of this group is 
fluoxetine and it is the most well known for use in pregnancy. 
No evidence of teratogenity in the children women who used 
fluoxetine, fluvoxamine, sertraline, and paroxetine during 
their pregnancies has been reported in the literature; however, 
some medical problems have occurred(53,54). According 
to some studies, early onset of labor and lower weight of 
the baby, lower APGAR scores and persistent pulmonary 
hypertension in the neonate have occurred when used in the 
late periods of pregnancy(53,54). When compared with other 
antidepressants, paroxetine was reported to lead to more 
congenital malformations, especially cardiac abnormalities, 
although the studies may have had conflictions; there is no 
Table 3. Treatment of antepartum depression
Mild-moderate depression
Psychotherapy 
Interpersonal psychotherapy
Cognitive behavioral psychotherapy
Severe depression
Failure in psychotherapy
Recurrent depressive Episodes
History of severe depression 
History of hospital admission  
Severe weight loss
Suicide attempts 
Medical treatment 
SSRI/Venlafaxine/Bupropion
Unresponsiveness to SSRI/Venlafaxine/Bupropion Tricyclic antidepressants/ECT
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definite conclusion(55-57). Neonates who are exposed to SSRIs 
in the third trimester can display symptoms of withdrawal 
(irritability, hypotonia, mild respiratory problems, and eating 
and sleeping disorders) but these can be easily treated with 
general support. Still, for the initial therapy, sertraline is 
the most recommended; citalopram is also an appropriate 
alternative.
For women with severe depression who do not respond to 
SSRIs, venlafaxine and bupropion should be chosen instead of 
other antidepressants (Grade 2C). In addition, electroconvulsive 
therapy can be considered.
Tricyclic Antidepressants: Even though there are differences 
between studies in the literature, the general consensus is that 
there is no increase in the risk of congenital malformations in 
neonates who are exposed to tricyclic antidepressants in the 
first trimester when compared with the general population. 
Functional intestinal obstruction and urinary retention 
can be seen in neonates due to anti-cholinergic adverse 
effects with all the tricyclic antidepressants. especially with 
clomipramine(58-64).
Electroconvulsive Therapy (ECT): Electroconvulsive therapy 
is recommended in the event that patients do not respond to 
psychotherapy and recurrent medical treatments (3-5 times). 
Especially in the major depression of the pregnant women, it 
is accepted as fast, reliable, and safe. In the literature, although 
some studies have reported fetal death, decrease in fetal heart rate, 
increase in uterine contractions, and early onset of labor, ECT is 
accepted today as an effective way to treat severe depression during 
pregnancy and its risks are minimal for mother and fetus(65-67).
Results
Mother and child health is one of the most important subjects of 
the World Health Oraganization’ a expectations for 2015 and for 
the Millennium Development Plans. In the past, even if the focus 
was only on the physical health of mother and child and mental 
health was ignored, today, the findings show that their physical 
and mental health cannot be separated and progress can be made 
only with them being combined. For this reason, knowing the 
risk factors of gestational and postpartum depression, and closely 
screening those at risk are important. It should be remembered 
that early diagnosis and treatment has positive effects on the 
physical and mental health of the mother and baby and their 
relationship(68). 
Gestational depression is as important as postpartum 
depression and should be diagnosed and treated early; 
however, it has not been considered as an important issue. 
Despite the many studies on gestational depression, only 
recently has the issue become important. Pregnancy is 
difficult period in terms of mental status and as yet, no 
standard for psychiatric support exists in Turkey even 
though gestational depression and anxiety are acknowledged 
to be very frequent, and importance is given to preterm care. 
Women with gestational depression are often not examined 
and consequently go untreated. When the effects on baby 
and mother are considered, women who are at risk of 
depression and anxiety must be identified early in healthcare 
centers, and should receive follow-up and treatment as 
required. During pregnancy, women should undergo the 
necessary assessments to maintain their physical and mental 
well-being, and these assessments ought to become a part 
of regular follow-ups. Healthcare providers who manage 
pregnant women should be educated about the frequency, 
symptoms, and screening methods of gestational and 
postpartum depression, the effects on mother and babyhs 
health if depression goes undiagnosed and untreated. In 
addition, clinicians must be informed about the risk factors 
of postpartum depression and the importance of watching 
closely for those exposed to these risks. Finally, depression-
screening programs should be formed in Turkey in which 
pregnant women are seen by professional groups in order 
to detect and prevent mental disorders, like they are in 
developed countries. Those who are detected as being at risk 
as a result of these screening programs should be referred for 
necessary treatment at appropriate centers.
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SUPPLEMENTS
Supplement 1. Patient Health Questionnaire (PHQ-9)
Over the last 2 weeks, how often have you been bothered by any of the following 
problems?  
Not 
at all
Several 
Days
More than 
half the days
Nearly 
every day
(Use “√” to indicate your answer)
1. Little interest or pleasure in doing things 0 1 2 3
2. Feeling down, depressed, hopeless 0 1 2 3
3. Trouble falling or staying asleep, or sleeping too much 0 1 2 3
4. Feeling tired or having little energy 0 1 2 3
5. Poor appetite or overeating 0 1 2 3
6. Feeling bad about yourself-or that you are a failure or have let yourself or your family down 0 1 2 3
7. Trouble concentrating on things, such as reading the newspaper or watching television 0 1 2 3
8. Moving or speaking so slowly that other people could have noticed. Or the opposite onily 
down:2dgety or restless that you have been moving around a lot more than usual 
0 1 2 3
9. Thoughts that you would be better off dead, or of hurting yourself 0 1 2 3
10. If you checked off any problems, how difficult have these problems made it for you to do 
your work, take care of things at home, or get along with other people? 
Not difficult at all    Somewhat difficult      Very difficult     Extremely difficult
 0  + _______ + _______ + _______ =TOTAL SCORE: ______
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Total Score Depression Severity
1-4 Minimal Depression
5-9 Mild Depression
10-14 Moderate Depression
15-19 Moderately severe depression
20-27 Severe depression
Supplement 2. Beck Depression Inventory 
1-     (0) I do not feel sad. 
        (1) I feel sad much of the time. 
        (2) I am sad all the time. 
        (3) I am so sad or unhappy that I can’t stand it.
2-     (0) I am not discouraged about my future.
        (1) I feel more discouraged about my future than I used to be.
        (2) I do not expect things to work out for me. 
        (3) I feel my future is hopeless and will only get worse. 
3-     (0) I do not feel like failure. 
        (1) I have failed more than I should have. 
        (2) As I look back, I see a lot of failures. 
        (3) I feel I am a total failure as a person. 
4-     (0) I get as much pleasure as I ever did from the things I enjoy.
        (1) I donut enjoy things as much as I used to. 
        (2) I get very little pleasure from the things I used to enjoy. 
        (3) I can’t get any pleasure from the things I used to enjoy
5-     (0) I donot feel particularly guilty. 
        (1) I feel guilty over many things I have done or should have done. 
        (2) I feel quite guilty most of the time. 
        (3) I feel guilty all of the time. 
6-     (0) I donot feel I am being punished. 
        (1) I feel I may be punished. 
        (2) I expect to be punished. 
        (3) I feel I am being punished. 
7-     (0) I feel the same about myself as ever. 
        (1) I have lost confidence in myself. 
        (2) I am disappointed in myself. 
        (3) I dislike myself. 
8-     (0) I donot criticize or blame myself more than usual. 
        (1) I am more critical of myself than I used to be. 
        (2) I criticize myself for all of my faults. 
        (3) I blame myself for everything bad that happens. 
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Supplement 2. Beck Depression Inventory
9-     (0) I do not have any thoughts of killing myself.
        (1) I have thoughts of killing myself, but I would not carry them out.
        (2) I would like to kill myself.
        (3) I would kill myself if I had the chance.
10-   (0) I do not cry anymore than I used to.
        (1) I cry more than I used to.
        (2) I cry over every little thing.
        (3) I feel like crying, but I can’t.
11-   (0) I am no more restless or wound up than usual. 
        (1) I feel more restless or wound up than usual. 
        (2) I am so restless or agitated that it’s hard to stay still. 
        (3) I am so restless or agitated that I have to keep moving or doing something.
12-   (0) I have not interest in other people or activities. 
        (1) I am less interested in other people or things than before. 
        (2) I have lost most of my interest in other people or things. 
        (3) It’s hard to get interested in anything. 
13-   (0) I make decisions about as well as ever. 
        (1) I find it more difficult to make decisions than usual.
        (2) I have much greater difficulty in making decisions than I used to. 
        (3) I have trouble making any decisions. 
14-   (0) I do not feel I am worthless.
        (1) I do not consider myself as worthwhile and useful as I used to. 
        (2) I feel more worthless as compared to other people. 
        (3) I feel utterly worthless. 
15-   (0) I have as much energy as ever. 
        (1) I have less energy than I used to have. 
        (2) I do not have enough energy to do very much. 
        (3) I do not have enough energy to do anything. 
16-   (0) I have not experienced any change in my sleeping pattern.
        (1a) I sleep somewhat more than usual.
        (1b) I sleep somewhat less than usual. 
        (2a) I sleep a lot more than usual.
        (2b) I sleep a lot less than usual. 
        (3a) I sleep most of the day.
        (3b) I wake up 1-2 hours early and can’t get back to sleep. 
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Supplement 2. Beck Depression Inventory
17-   (0) I am no more irritable than usual.
        (1) I am more irritable than usual. 
        (2) I am much more irritable than usual. 
        (3) I am irritable all the time. 
18-   (0) I have not experienced any change in my appetite.
        (1a) My appetite is somewhat less than usual. 
        (1b) My appetite is somewhat greater than usual. 
        (2a) My appetite is much less than before. 
        (2b) My appetite is much greater than usual.
        (3a) I have no appetite at all.
        (3b) I crave food all the time. 
19-   (0) I can concentrate as well as ever.
        (1) I can’t concentrate as well as usual.
        (2) It’s hard to keep my mind on anything for very long.
        (3) I find I can’t concentrate on anything.
20-   (0) I am no more tired or fatigued than usual.
        (1) I get more tired or fatigued more easily than usual.
        (2) I am too tired or fatigued to do a lot of the things I used to do.
        (3) I am too tired or fatigued to do most of the things I used to do.
21-   (0) I have not noticed any recent change in my interest an sex.
        (1) I am less interested in sex than I used to be.
        (2) I am much less interested in sex now.
        (3) I have lost interest in sex completely.
Scoring: There is a four-point scale for each item ranging from 0 to 3. On two items (16 and 18) there are seven options to indicate either an increase or decrease of appetite and sleep. Total 
score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.
Supplement 3. Center for Epidemiologic Studies Depression (CES-D)
Below is a list of some ways you may have felt or behaved. Please indicate how 
often you have felt this way during the last week by checking the appropriate space. 
Please only provide one answer to each question. 
Rarely
(<1 day)
Some 
(1-2 day)
Occasionally
(3-4 day)
 Most
(5-7 day)
I was bothered by things that usually don’t bother me. o o o o
I didn’t feel like eating; my appetite was poor. o o o o
I felt that I couldn’t shake off the blues even with help from my family or friends. o o o o
I felt I was just as good as other people. o o o o
I had trouble keeping my mind on what I was doing. o o o o
I felt depressed. o o o o
I felt that everything I did was an effort. o o o o
I felt hopeful about the future.   o o o o
I thought my life had been a failure. o o o o
I felt fearful. o o o o
My sleep was restless. o o o o
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Supplement 3. Center for Epidemiologic Studies Depression (CES-D)
Below is a list of some ways you may have felt or behaved. Please indicate how 
often you have felt this way during the last week by checking the appropriate 
space. Please only provide one answer to each question. 
Rarely
(<1 day)
Some 
(1-2 day)
Occasionally
(3-4 day)
 Most
(5-7 day)
I was happy. o o o o
I talked less than usual. o o o o
I felt lonely. o o o o
People were unfriendly. o o o o
I enjoyed life. o o o o
I had crying spells.   o o o o
I felt sad.  o o o o
I felt that people disliked me. o o o o
I could not get going. o o o o
Scoring Rarely Some Occasionally Most 
Questions 4, 8, 12, 16 3 2 1 0
All other questions 0 1 1 3
The score is the sum of the 20 questions. Possible range is 0-60. If more than four questions are missing answers, do not score the CES-D questionnaire. A score of 16 points or more is 
considered depressed. 
Supplement 4. Edinburgh Postnatal Depression Scale (EPDS)
As you are pregnant or have recently had a baby, we would like to know how you are feeling. Please check the answer that comes 
closest to how you have felt IN THE PAST 7 DAYS, not just how you feel today. 
1. I have been able to laugh and see the funny side of things
---As much as I always could      0
---Not quite so much now      1
---Definitely not so much now     2
---Not at all        3
2. I have looked forward with enjoyment to things
---As much as I ever did      0
---Rather less than I used to      1
---Definitely less than I used to     2
---Hardly at all       3
3. I have blamed myself unnecessarily when things went wrong
---Yes, most of the time      3
---Yes, some of the time      2
---Not very often       1
---No, never       0
4. I have been anxious or worried for no good reason
---No, not at all       0
---Hardly ever       1
---Yes, sometimes       2
---Yes, very often       3
5. I have felt scared or panicky for no very good reason
---Yes, quite a lot       3
---Yes, sometimes       2
---No, not much       1
---No, not at all       0
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Supplement 4. Edinburgh Postnatal Depression Scale (EPDS)
As you are pregnant or have recently had a baby, we would like to know how you are feeling. Please check the answer that comes 
closest to how you have felt IN THE PAST 7 DAYS, not just how you feel today. 
6. Things have been getting on top of me
---Yes, most of the time I haven’t been able to cope at all   3
---Yes, sometimes I haven’t been coping as well as usual   2
---No, most of the time I have coped quite well    1
---No, I have been coping as well as ever    0
7. I have been so unhappy that I have had difficulty sleeping
---Yes, most of the time      3
---Yes, sometimes       2
---Not very often       1
---No, not at all       0
8. I have felt sad 
---Yes, most of the time      3
---Yes, quite often       2
---Not very often       1
---No, not at all       0
9. I have been so unhappy that I have been crying
---Yes, most of the time      3
---Yes, quite often        2
---Only occasionally      1
---No, never       0
10. The thought of harming myself has occurred
---Yes, quite often       3
---Sometimes       2
---Hardly ever        1
---Never        0
Scoring: The score is the sum of the 10 questions. Possible range is 0-30. A score of 13 points or more is considered depressed.
